Granulomatosis with Polyangiitis following COVID-19 in an Adolescent
- PMID: 36792217
- PMCID: PMC10017231
- DOI: 10.2169/internalmedicine.1109-22
Granulomatosis with Polyangiitis following COVID-19 in an Adolescent
Abstract
Granulomatosis with polyangiitis (GPA) is a systemic disease that causes vasculitis in various organs. Although the mechanism of pathogenesis remains unclear, infection has been reported to be a causative factor. We herein report a case of GPA that developed following coronavirus disease 2019 (COVID-19) in an adolescent girl. One month after contracting mild COVID-19, the patient had facial allodynia, a fever, and weight loss and was admitted for multiple nodular shadows on a chest roentgenogram. GPA was diagnosed based on pathological findings of the lung and nasal mucosal biopsies. She received methylprednisolone and rituximab, and her symptoms and radiological findings improved.
Keywords: coronavirus disease 2019; facial allodynia; granulomatosis with polyangiitis; multiple lung nodules; proteinase-3-antineutrophil cytoplasmic antibody; rituximab.
Conflict of interest statement
Figures
References
-
- Lutalo PM, D'Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis). J Autoimmun 48-49: 94-98, 2014. - PubMed
-
- Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 20: 1010-1036, 1995. - PubMed
-
- Kallenberg CG. The role of bacterial infections for the initiation and exacerbation of systemic vasculitis. Autoimmun Rev 3: S45-S47, 2004. - PubMed
